Agenda






Bioprocessing Venture, Innovation & Partnering Conference
Innovation & Investment for Manufacturing Biologics & Advanced Therapeutics
August 21, 2024 ALL TIMES EDT
The 2nd Annual Bioprocessing Venture, Innovation & Partnering Conference brings together leading investors, innovators, manufacturers, and suppliers who are driving the future of bioprocessing. This partnering conference aims to bring together C-level executives from investment firms, biopharmaceutical manufacturers, CDMOs, equipment suppliers, and innovative startups to discuss the most timely and important issues facing innovation in bioprocessing. We will include strategies from big and small pharma, venture, and corporate arms who have a vested interest in driving this innovation, plus CEOs and innovators from across the biologic, cell, and gene therapy space. This unique combination offers the opportunity to participate in a venture and partnering event featuring a very exciting and emerging space, while also offering the chance to visit the Exhibit Hall and meet companies and get a sense of where this industry is going.

Wednesday, August 21

    Registration and Networking Coffee

    Morning Sessions

    Organizer's Welcome Remarks

    Nandini Kashyap, M.Pharm., Senior Director, Conferences and Social Media Strategy, Cambridge Innovation Institute , Senior Director, Conferences and Social Media Strategy , Cambridge Innovation Institute

    Co-Chairperson's Opening Remarks

    Ann Lee, PhD, CTO, Prime Medicine, Inc. , CTO , Prime Medicine Inc

    Ran Zheng, CEO, Landmark Bio , Chief Executive Officer , Landmark Bio

    Panel Moderator:

    PANEL DISCUSSION:
    Investor Panel: Investment Trends in Life Science Industrial Innovation

    Ann Lee, PhD, CTO, Prime Medicine, Inc. , CTO , Prime Medicine Inc

    Panelists:

    David Q. Anderson, General Partner, Ampersand Capital Partners , General Partner , Ampersand Capital Partners

    Philip Vanek, CTO, Gamma Biosciences , Chief Technology Officer , Gamma Biosciences

    Alex De Winter, PhD, Vice President New Ventures, Danaher Corp. , VP New Ventures , New Ventures , Danaher Corp

    Chenny Zhang, Director, Cerberus Ventures , Director , Cerberus Ventures

    Panel Moderator:

    PANEL DISCUSSION:
    Exit Strategies: M&A vs. IPO Debate

    Peter Lee, Partner, Avant Bio , Partner , Avant Bio

    Panelists:

    Audrey Greenberg, Founder & Officer, CBM, SK pharmteco , Founder and Chief Business Officer, CBM , SK pharmteco

    Bryan Kipp, Senior Vice President, Technology and Licensing, Revvity, Inc. , Senior Vice President , Technology and Licensing , Revvity, Inc

    Prem Tumkosit, Managing Director, Global Health Innovation Fund, Merck & Co. , Managing Director , Global Health Innovation Fund , Merck Global Health Innovation Fund

    Networking Coffee Break

    KEYNOTE FIRESIDE CHAT:
    Life Science Executive

    Konstantina Katcheves, Senior Vice President, Business Development, Alliance Management and Acquisitions, Teva Pharmaceuticals , SVP Business & Corporate Development, Global Innovative Medicinces , Bus Dev , Teva Pharmaceuticals

    Philip Vanek, CTO, Gamma Biosciences , Chief Technology Officer , Gamma Biosciences

    KEYNOTE PRESENTATION:
    Betting Big on Advanced Therapies

    Photo of Emmanuel Abate, President, Genomic Medicine and Head of Sustainability, Cytiva , President, Genomic Medicine and Head of Sustainability , Cytiva
    Emmanuel Abate, President, Genomic Medicine and Head of Sustainability, Cytiva , President, Genomic Medicine and Head of Sustainability , Cytiva

    Expectations on the biopharma industry are huge. Fundamentals are strong but the challenges are diverse and rapid-fire. We’ll look at how collaboration and innovation are key to overcoming challenges and providing patients with the next generation of therapies for better living.

    Networking Lunch

    PM Panels

    Co-Chairperson's Remarks

    Ann Lee, PhD, CTO, Prime Medicine, Inc. , CTO , Prime Medicine Inc

    Panel Moderator:

    PANEL DISCUSSION:
    AI & Technology Panel: Navigating Innovation, Technological Advancements, and Evolving Regulations

    Lori Ellis, Head of Insights, BioSpace , Head , Insights , BioSpace

    Panelists:

    Sherrine M. Eid, Global Head, Real World Evidence & Epidemiology, SAS Institute, Inc. , Global Head , Real World Evidence & Epidemiology , SAS Institute Inc

    Sarah Glaven, Principal Assistant Director, Biotechnology and Biomanufacturing, White House Office of Science and Technology Policy , Principal Assistant Director , Biotechnology and Biomanufacturing , White House Office of Science and Technology Policy

    Nagisa Sakurai, PhD, Senior Investment Manager, Astellas , Sr Investment Manager , Astellas

    Mike J. Walker, Executive Director - Life Sciences Supply Chain, Microsoft , Executive Director - Life Sciences Supply Chain , Microsoft

    Colin Zick, Partner, Foley Hoag LLP , Partner , Foley Hoag LLP

    Panel Moderator:

    PANEL DISCUSSION:
    How CEOs Are Navigating the Ups and Downs during Uncertain Times

    Ran Zheng, CEO, Landmark Bio , Chief Executive Officer , Landmark Bio

    Panelists:

    Steven J. Favaloro, President & CEO, Genezen , President & CEO , Genezen

    Patrick Lucy, President and CEO, RoslinCT US , President and CEO , RoslinCT US

    Rahul Singhvi, ScD, Co-Founder & CEO, Resilience , Co-Founder & CEO , Resilience

    Networking Refreshment Break

    Panel Moderator:

    PANEL DISCUSSION:
    CDMO Panel: Advancing Collaborations and Partnerships

    Gil Y. Roth, President, PBOA Pharma & BioPharma Outsourcing Association , President , PBOA Pharma & BioPharma Outsourcing Association

    Panelists:

    Robert Hughes, Global Head of Technical Operations, Galapagos , Global Head of Technical Operations , Galapagos

    Ulrike Lemke, Business Unit President, Sterile Fill & Finish, Recipharm AG , Business Unit President , Sterile Fill & Finish , Recipharm AG

    Georgia Sloboda, Managing Director, CMC, Latham BioPharm Group , Managing Dir Chemistry Mfg & Controls , Chemistry Mfg & Controls , Latham BioPharm Group

    Samuel Chuang, PhD, Director Scientific Advisory Services, Charles River Laboratories , Dir Scientific Advisory Svcs , Scientific Advisory Svcs , Charles River Labs

    Co-Chairperson's Closing Remarks

    Ran Zheng, CEO, Landmark Bio , Chief Executive Officer , Landmark Bio

    Networking Reception in the Exhibit Hall

    Close of Day


    SPONSORSHIP & EXHIBIT OPPORTUNITIES

    Market Strategy or Technology Presentation

    • 10 or 20 dedicated minutes of stage time to present clinical market research and/or data trends

      Branding Opportunities 

      • Coffee/lunch/networking breaks
      • Lanyard & badge wallet sponsorship
      • Notebook give-away

      All sponsorships include: 

      • VIP conference registrations (and discounted registration to attend the Bioprocessing Summit)
      • Pre-conference blinded (company/title) attendee list
      • Post-conference GDPR-approved full demo attendee list
      • Pre/on-site/post event signage and designation as event sponsor
      • On-site announcement and recognition as event partner/sponsor

        To learn more about Sponsorship opportunities and how you can play an active role at the conference while networking with the nation’s leading innovators, investors and executives please contact:

        Brian Caine
        Specialized Business Development Manager
        908-809-0946
        bcaine@healthtech.com